80 related articles for article (PubMed ID: 35211690)
1. Randomized singular value decomposition for integrative subtype analysis of 'omics data' using non-negative matrix factorization.
Ni Y; He J; Chalise P
Stat Appl Genet Mol Biol; 2023 Jan; 22(1):. PubMed ID: 37937887
[TBL] [Abstract][Full Text] [Related]
2. Statistical Methods for Integrative Clustering of Multi-omics Data.
Chalise P; Kwon D; Fridley BL; Mo Q
Methods Mol Biol; 2023; 2629():73-93. PubMed ID: 36929074
[TBL] [Abstract][Full Text] [Related]
3. scMoMaT jointly performs single cell mosaic integration and multi-modal bio-marker detection.
Zhang Z; Sun H; Mariappan R; Chen X; Chen X; Jain MS; Efremova M; Teichmann SA; Rajan V; Zhang X
Nat Commun; 2023 Jan; 14(1):384. PubMed ID: 36693837
[TBL] [Abstract][Full Text] [Related]
4. Deep learning in cancer genomics and histopathology.
Unger M; Kather JN
Genome Med; 2024 Mar; 16(1):44. PubMed ID: 38539231
[TBL] [Abstract][Full Text] [Related]
5. Proteomic Profile Distinguishes New Subpopulations of Breast Cancer Patients with Different Survival Outcomes.
Tobiasz J; Polanska J
Cancers (Basel); 2023 Aug; 15(17):. PubMed ID: 37686507
[TBL] [Abstract][Full Text] [Related]
6. Identifying a distinct fibrosis subset of NAFLD via molecular profiling and the involvement of profibrotic macrophages.
He W; Huang Y; Shi X; Wang Q; Wu M; Li H; Liu Q; Zhang X; Huang C; Li X
J Transl Med; 2023 Jul; 21(1):448. PubMed ID: 37415134
[TBL] [Abstract][Full Text] [Related]
7. Missing data in multi-omics integration: Recent advances through artificial intelligence.
Flores JE; Claborne DM; Weller ZD; Webb-Robertson BM; Waters KM; Bramer LM
Front Artif Intell; 2023; 6():1098308. PubMed ID: 36844425
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneous data integration methods for patient similarity networks.
Gliozzo J; Mesiti M; Notaro M; Petrini A; Patak A; Puertas-Gallardo A; Paccanaro A; Valentini G; Casiraghi E
Brief Bioinform; 2022 Jul; 23(4):. PubMed ID: 35679533
[TBL] [Abstract][Full Text] [Related]
9. [Advance of molecular subtyping and precise treatment for gliomas].
Hua W; Mao Y
Zhonghua Wai Ke Za Zhi; 2017 Jan; 55(1):63-66. PubMed ID: 28056258
[TBL] [Abstract][Full Text] [Related]
10. Clinical impact of revisions to the WHO classification of diffuse gliomas and associated future problems.
Sonoda Y
Int J Clin Oncol; 2020 Jun; 25(6):1004-1009. PubMed ID: 32020379
[TBL] [Abstract][Full Text] [Related]
11. Detecting molecular subtypes from multi-omics datasets using SUMO.
Sienkiewicz K; Chen J; Chatrath A; Lawson JT; Sheffield NC; Zhang L; Ratan A
Cell Rep Methods; 2022 Jan; 2(1):. PubMed ID: 35211690
[TBL] [Abstract][Full Text] [Related]
12. Protocol for integrative subtyping of lower-grade gliomas using the SUMO pipeline.
Sienkiewicz K; Ratan A
STAR Protoc; 2022 Mar; 3(1):101110. PubMed ID: 35106500
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional Characteristics of
Chang YZ; Li GZ; Pang B; Zhang KN; Zhang XH; Wang YZ; Jiang ZL; Chai RC
Front Cell Dev Biol; 2020; 8():580464. PubMed ID: 33195221
[No Abstract] [Full Text] [Related]
14. TERT promoter mutation status is necessary and sufficient to diagnose IDH-wildtype diffuse astrocytic glioma with molecular features of glioblastoma.
Fujimoto K; Arita H; Satomi K; Yamasaki K; Matsushita Y; Nakamura T; Miyakita Y; Umehara T; Kobayashi K; Tamura K; Tanaka S; Higuchi F; Okita Y; Kanemura Y; Fukai J; Sakamoto D; Uda T; Machida R; Kuchiba A; Maehara T; Nagane M; Nishikawa R; Suzuki H; Shibuya M; Komori T; Narita Y; Ichimura K
Acta Neuropathol; 2021 Aug; 142(2):323-338. PubMed ID: 34148105
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
